Elite Pharmaceuticals Inc. Overview
Elite Pharmaceuticals, Inc., a health care company based in Northvale, United States, operates within the pharmaceutical sector. The company specializes in the research, development, licensing, and manufacturing of both new and generic oral controlled-release pharmaceutical products. Its product portfolio includes pain management products currently in clinical trials, as well as therapeutic agents for cardiovascular, antidiabetic, and anti-infective applications, along with cough and cold preparations. More information about Elite Pharmaceuticals’ activities and offerings can be found on their website at www.elitepharma.com . The company is publicly traded on the Other-OTC stock exchange and went public on July 23, 1998.
Recent Stock Performance
As of May 12, 2025, Elite Pharmaceuticals’ stock price has stabilized at $0.43598 USD. This stabilization follows the commercial launch of Oxycodone and Acetaminophen Tablets, a significant development for the company. The stock reached a 52-week high of $0.7549 USD on October 21, 2024, marking a peak in recent market activity. In contrast, the 52-week low was recorded at $0.13 USD on May 12, 2024, underscoring the asset’s historical volatility.
Financial Metrics
The company’s current price-to-earnings ratio stands at -25.39, indicating challenges in profitability. Meanwhile, the book ratio is reported at 12.46. These financial metrics provide a technical snapshot of Elite Pharmaceuticals’ financial performance, reflecting both the company’s market valuation and its underlying asset value.
Market Capitalization
Elite Pharmaceuticals Inc. has a market capitalization of $454,020,000 USD, positioning it within the broader health care sector. This valuation reflects the company’s current market standing and investor sentiment.
In summary, Elite Pharmaceuticals Inc. continues to focus on expanding its product offerings and navigating the complexities of the pharmaceutical market. The recent stabilization of its stock price and the launch of new products are key developments for the company as it moves forward.